Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 4/20 | 0.51 |
| ▸ | ELANE | P08246 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | PRTN3 | P24158 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | KLK1 | P06870 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18973478 | 0.91 | BTN3A1 (0.52) | BTN3A1ELANETP53PRTN3ALDH1A1 | |
| SCHEMBL22065701 | 0.88 | BTN3A1 (0.53) | BTN3A1ELANETP53PRTN3KLK1 | |
| SCHEMBL18973471 | 0.88 | TP53 (0.56) | BTN3A1ELANETP53PRTN3ALDH1A1 | |
| SCHEMBL18973482 | 0.87 | BTN3A1 (0.49) | BTN3A1ELANETP53PRTN3ALDH1A1 | |
| SCHEMBL24505391 | 0.87 | BTN3A1 (0.60) | BTN3A1ELANETP53PRTN3ALDH1A1 | |
| SCHEMBL18973549 | 0.87 | BTN3A1 (0.60) | BTN3A1ELANETP53PRTN3ALDH1A1 | |
| SCHEMBL22066289 | 0.84 | BTN3A1 (0.52) | BTN3A1ELANETP53PRTN3HPGD | |
| SCHEMBL22066286 | 0.84 | BTN3A1 (0.49) | BTN3A1ELANETP53PRTN3ALDH1A1 | |
| SCHEMBL18973573 | 0.84 | BTN3A1 (0.49) | BTN3A1ELANETP53PRTN3ALDH1A1 | |
| SCHEMBL15593268 | 0.84 | BTN3A1 (0.49) | BTN3A1ELANETP53PRTN3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210009625-A1 | DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES | LAURUS LABS PRIVATE LTD (IN) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210009625-A1 | DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES | TYMP, PNP, DPYD | BTN3A1 4228/4885ELANE 4731/4885TP53 522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.